ITEM 8.01 OTHER EVENTS
Stryker Corporation (NYSE:SYK) received a warning letter dated May 5, 2009
from the U.S. Food and Drug Administration (FDA) related to compliance issues
for one of its craniomaxillofacial (CMF) implant products that was previously
sold through its CMF distribution facility in Portage, Michigan. The Company
is in the process of responding to the FDA regarding this matter.
On May 7, 2009, the Company received a subpoena from the Attorney General
of New Jersey requesting various documents related to the financial interests
and arrangements of physicians participating in certain clinical trials for or
on behalf of the Company. The Company is evaluating the scope of the subpoena
and its response. The Attorney General of New Jersey reportedly issued similar
subpoenas to other major medical device manufacturing companies.
Add
SYK to Portfolio
Set Alert
Email to a
Friend